Anthony Rodgers's Publications
About Anthony Rodgers's Publications
Professorial Fellow, Professoriate- Professor of Global Health, Faculty of Medicine, UNSW Sydney
- Chair of Clinical Epidemiology, Faculty of Medicine, Imperial College of London
-
Effects of Low-dose Triple Combination Therapy on Time at Target Blood Pressure - Results From the TRIUMPH Randomized Controlled Trial
Heart, Lung and Circulation Date published: -
Patient Acceptability of Polypill Treatment for Hypertension: A Qualitative Study From the QUARTET Trial
Heart, Lung and Circulation Date published: -
Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine
AIDS Date published: -
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019
Journal of the American College of Cardiology Date published: -
Cardiovascular preventive strategies are not conflicting
The Lancet Date published: -
Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension
JAMA Cardiology Date published: -
Association between comorbidities and blood pressure trajectories in patients with hypertension
European Heart Journal Date published: -
Preferences for Tobacco Cessation Information and Support During Covid-19
Journal of Addiction Medicine Date published: -
A digital health intervention for cardiovascular disease management in primary care (CONNECT) randomized controlled trial
npj Digital Medicine Date published: -
Two-drug fixed-dose combinations of blood pressure-lowering drugs as WHO essential medicines: An overview of efficacy, safety, and cost
The Journal of Clinical Hypertension Date published: -
Regression to the mean in home blood pressure: Analyses of the BP GUIDE study
The Journal of Clinical Hypertension Date published: -
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Journal of the American Heart Association Date published: -
Optimising TRIUMPH with 6·25 mg chlorthalidone - Authors' reply
The Lancet Global Health Date published: -
Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants
The Lancet Diabetes & Endocrinology Date published: -
471 Cumulative Benefits of Cholesterol Lowering for the Prevention of Cardiovascular Events
Heart, Lung and Circulation Date published: -
The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program
The Lancet Rheumatology Date published: